Product Information
ETRAVIRINE 200 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $11.4115 per EA under NDC 69452025517. Its NADAC has been published 21 times since Feb 4, 2026.
Strength
200 mg/1
Manufacturer
Bionpharma Inc.NDC
69452025517
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ETRAVIRINEApproval Type
Generic (ANDA)
FDA Application
ANDA219152On Market Since
1/1/2026
Pharmacological Classes
Price Statistics
The NADAC for ETRAVIRINE 200 MG TABLET has been published 21 times since Feb 4, 2026, and over the history we have for it it has declined 2.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.4115 per EA |
|---|---|
| All-time high | $11.7118 (Feb 11, 2026) |
| All-time low | $11.2785 (May 20, 2026) |
| 52-week high | $11.7118 |
| 52-week low | $11.2785 |
| Median price | $11.4998 |
| Average price | $11.4713 |
| Largest weekly change | -1.6% (Mar 18, 2026) |
| Weeks tracked | 21 |
| Tracking since | Feb 4, 2026 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ETRAVIRINE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ETRAVIRINE 200 MG TABLET, manufactured by Bionpharma Inc., is $11.4115 per EA (NDC 69452025517), effective Jun 24, 2026.
How has the price of ETRAVIRINE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for ETRAVIRINE 200 MG TABLET has declined 2.6%. It has been tracked across 21 weekly CMS publications since Feb 4, 2026.
What are the highest and lowest recorded NADAC prices for ETRAVIRINE 200 MG TABLET?
Since Feb 4, 2026, the NADAC for ETRAVIRINE 200 MG TABLET has ranged from a low of $11.2785 (May 20, 2026) to a high of $11.7118 (Feb 11, 2026), with a median of $11.4998 per EA.
Are there cheaper alternatives to ETRAVIRINE 200 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as ETRAVIRINE 200 MG TABLET, but none are currently priced below it.
Who manufactures ETRAVIRINE 200 MG TABLET?
ETRAVIRINE 200 MG TABLET (NDC 69452025517) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification